Prospect Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$258K Buy
10,711
+3,505
+49% +$91.7K 0.13% 94
2026
Q1
$202K Buy
+7,206
New +$192K 0.12% 102
2025
Q4
Sell
-8,126
Closed -$207K 111
2025
Q3
$207K Sell
8,126
-993
-11% -$24.5K 0.12% 101
2025
Q2
$221K Buy
9,119
+166
+2% +$3.87K 0.14% 95
2025
Q1
$227K Sell
8,953
-5,435
-38% -$142K 0.13% 103
2024
Q4
$382K Sell
14,388
-4,514
-24% -$122K 0.21% 73
2024
Q3
$547K Buy
18,902
+2,932
+18% +$85.5K 0.34% 49
2024
Q2
$447K Buy
15,970
+28
+0.2% +$771 0.34% 49
2024
Q1
$442K Buy
15,942
+2,864
+22% +$79.5K 0.37% 49
2023
Q4
$377K Buy
+13,078
New +$395K 0.38% 46

Other funds holding PFE

Prospect Financial Services's PFE Position: Q2 2026 in Review

Prospect Financial Services increased its Pfizer (PFE) stake by 49% in Q2 2026, buying an estimated $91.7K and bringing the position to 10,711 shares worth $258K. The position accounts for 0.13% of the portfolio, ranked #94.

Prospect Financial Services first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $547K in Q3 2024. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Prospect Financial Services held 10,711 shares of Pfizer worth $258K as of Q2 2026.
  • Prospect Financial Services bought 3,505 Pfizer shares in Q2 2026, an estimated $91.7K.
  • Pfizer made up 0.13% of Prospect Financial Services's portfolio in Q2 2026, its #94 holding.
  • Prospect Financial Services first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Prospect Financial Services's Pfizer position peaked at $547K in Q3 2024.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Prospect Financial Services's 13F filing for Q2 2026, filed 6 Aug 2026.